Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02196 FOSUN PHARMA
RT Nominal down15.540 -0.660 (-4.074%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others20,446,847-1.917%20,846,45815,718,78913,012,07512,579,873
Land & other Lease Assets4,130,816-2.760%4,248,0802,837,2292,569,7962,666,402
Intangible Assets26,596,4531.693%26,153,78724,288,67821,010,69918,254,990
Interests in Asso. & JCEs25,066,3484.963%23,881,02323,094,05522,626,82722,252,582
Other Non-current Assets4,461,059-1.070%4,509,3105,895,2623,593,1312,790,473

80,701,5231.335%79,638,65871,834,01362,812,52858,544,320
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories7,511,699-0.346%7,537,7686,882,4325,472,5475,162,800
Trade Receivables8,246,2477.538%7,668,2297,612,9426,045,9474,807,059
Cash & Bank Balances14,080,4592.825%13,693,59116,241,31310,317,2249,961,802
Other Current Assets4,887,534-0.111%4,892,9814,122,9128,137,4835,153,142
Assets Held for Sale71,976--0419,578463,7050

34,797,9152.975%33,792,56935,279,17730,436,90625,084,803
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables6,525,9455.947%6,159,6196,284,0415,063,6933,289,021
S-T Debt & Leases22,834,57317.502%19,433,26717,214,87715,626,08115,033,109
Other Current Liabilities8,041,343-1.511%8,164,6959,799,1528,628,6996,550,223
Liab asso w/ Assets Held for Sale0--0000

37,401,86110.795%33,757,58133,298,07029,318,47324,872,353
Net Current Assets(2,603,946)--34,9881,981,1071,118,433212,450
Total Assets Less Current Liabilities78,097,577-1.978%79,673,64673,815,12063,930,96158,756,770
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases11,757,177-24.413%15,554,51212,844,8609,697,4299,102,976
Other Non-current Liabilities7,516,834-0.324%7,541,2496,912,0675,910,8503,726,398

19,274,011-16.547%23,095,76119,756,92715,608,27912,829,374
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital2,672,3990.000%2,672,3992,672,1572,562,8992,562,899
  Reserves44,256,4252.984%42,973,98741,859,58436,575,77334,375,748
  Others0--0000
Shareholders' Funds46,928,8242.810%45,646,38644,531,74139,138,67236,938,647
Non-controlling Interests11,894,7428.812%10,931,4999,526,4529,184,0108,988,749
Others0--0000

58,823,5663.969%56,577,88554,058,19348,322,68245,927,396
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----4,282,7986,469,8437,774,3827,826,105
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 03/10/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 1,224,799
%Change-31.332%
EPS / (LPS)RMB 0.460
NBV Per Share (¥)RMB 17.561
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.